BioCentury
ARTICLE | Company News

Novartis, TB Alliance deal

September 1, 2014 7:00 AM UTC

Novartis granted the alliance exclusive, worldwide rights to the portfolio of preclinical tuberculosis (TB) compounds discovered at the Novartis Institutes for Tropical Diseases (NITD). The portfolio ...